nilotinib Capsules
for oral use Initial U.S. Approval: 2007

Tasigna (nilotinib) is a prescription medicine used to treat chronic myelogenous leukaemia (CML) in patients who have the Philadelphia chromosome. It may be used in people who have been newly diagnosed or who cannot take other cancer medicines (including imatinib).

Facts about nilotinib Capsules

Disease Indications-Leukemia
Manufacturer-Novartis
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA),  Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “nilotinib Capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Ponatinib injection
for subcutaneous use Initial U.S. Approval: 2012

Ponatinib tablets is “used to treat patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Ph+ ALL for whom no other tyrosine kinase inhibitor (TKI)“. ICLUSIG Tablets is a “prescription medicine”. It is available in “form and strength” Tablets: 15 mg and 45 mg. ICLUSIG Tablets can be obtained in India upon request.
To inquire about the ICLUSIG (ponatinib) tablets“offer price in India”, “shipping process”, and the “estimated time of availability in India”, please get in touch at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.”

Facts about your medicine

Approval Date: 2012
Proprietary Name: On Request
Active Ingredient(s): Ponatinib tablets
Dosage Forms And Strengths:
Manufacturer:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Venetoclax Tablets
for oral use Initial U.S. Approval: 2016

Venetoclax tablets is “used to treat Chronic Lymphocytic Leukemia (CLL) or in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia (AML)“. VENCLEXTA tablets is a “prescription medicine”. It is available in “form and strength” Tablets: 10 mg, 50 mg, 100 mg. VENCLEXTA for injection can be obtained in India upon request.
To inquire about the VENCLEXTA (venetoclax tablets) “offer price in India”, “shipping process”, and the “estimated time of availability in India”, please get in touch at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.”

Facts about your medicine

Name: Venclyxto
Active substance: Venetoclax
Therapeutic area: Leukemia, Lymphocytic, Chronic, B-Cell
Marketing Authorisation: 04/12/2016.
AUTHORISED: This medicine is authorised for use in the European Union.
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)